4-YEAR FOLLOW-UP OF THE FIRST CLINICAL APPLICATION OF THE IN VIVO TISSUE ENGINEERED VASCULAR GRAFT TO CONGENITAL HEART DISEASE: POTENTIAL FOR ADAPTABILITY TO PATIENT GROWTH.
4-YEAR FOLLOW-UP OF THE FIRST CLINICAL APPLICATION OF THE IN VIVO TISSUE ENGINEERED VASCULAR GRAFT TO CONGENITAL HEART DISEASE: POTENTIAL FOR ADAPTABILITY TO PATIENT GROWTH.
复制标题
体内组织工程血管移植物首次临床应用治疗先天性心脏病的 4 年随访：适应患者生长的潜力。
DOI：
--
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Hitoshi Yaku
中科院分区：
文献类型：
--
作者：
Shuhei Fujita;Masaaki Yamagishi;Keiichi Kanda;Yoshinobu Maeda;Masashi Yamanami;Taiji Watanabe;Hitoshi Yaku
